Chandigarh: The Department of Neurosurgery at the PGI here on Tuesday said it has started operating patients with 3D exoscope, a first in the country.
For two patients with a brain tumour and orbital mass, neurosurgeon Dhandapani and his team performed 3D exoscope surgery successfully, it said.
Also Read:Female chaperon necessary while examination of female patient by male doctor: PGIMER adopts updated charter
This technology is one of the latest advances in minimally invasive brain and spine surgery. The 3D visualisation is guided by scope from outside, compared to the usual 2D visualisation from inside in the endoscope.
Many centres in India have 2D exoscopes, but 3D exoscope in the Postgraduate Institute of Medical Education and Research is the first in India.
This is very helpful to deal with problems on the surface of the brain, spine, and orbit. Compared to a microscope, the system is lighter, occupies less operating room space, and is ergonomically better, a PGI statement said.
This procedure would be of great benefit to patients with brain and spine problems, it added.
Also Read: PGI Chandigarh authorities call protesting Nurses Welfare Association to discuss demands
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!